Newborns can't see clearly at birth. In fact, vision is about 20/400, making the first days of sight very blurry, like a camera out of focus. But within a week, a baby can focus on objects about 8 to 12 inches from his face.
(Wellâ¦sort of ânew.â) Tresiba is a long-acting insulin (like Lantus or Levemir) made by NovoNordisk. Itâs been available in Europe for several years now and is still awaiting FDA approval in the USA. (UPDATE: Tresiba is now approved by the FDA for use in the USA!)
On Lantus and Levemir, you're pretty much stuck to the same limited window of opportunity before your basal insulin runs out and your blood sugar starts climbing. On degludec, with a longer half-life and duration of action, there is even more freedom and flexibility to adjust when the injection is taken.